Sciencast Management LP Repligen Corp Transaction History

Sciencast Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$138.42 - $180.31 $249,571 - $325,098	1,803 New	1,803 $255,000
Q1 2022 Apr 26, 2022	SELL	$161.19 - $257.96 $697,630 - $1.12 Million	-4,328 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$247.59 - $304.47 $1.07 Million - $1.32 Million	4,328 New	4,328 $1.01 Million
Q2 2021 Jul 28, 2021	SELL	$165.87 - $220.95 $678,242 - $903,464	-4,089 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$180.37 - $226.26 $737,532 - $925,177	4,089 New	4,089 $841,000
Q4 2020 Feb 04, 2021	SELL	$148.08 - $206.57 $596,614 - $832,270	-4,029 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$122.51 - $158.27 $493,592 - $637,669	4,029 New	4,029 $702,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

Stay updated on Sciencast Management LP with notifications on news.